Showing results (201-210 of 484) with videos related to

Sort By:
Pageof 49
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete|December 1, 1988
[The value of hypertension and metabolic factors on the development of coronary heart disease in type II diabetic patients]H Schmechel, J Schulze, M Hanefeld, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|August 17, 2001
Search for mitochondrial DNA mutation at position 3243 in German patients with a positive family history of maternal diabetes mellitusT Klemm, S Neumann, B Trülzsch, et al.
Fortschritte Der Medizin|December 20, 1992
[Different effects of fibrates on the lipoprotein profile. Comparison of the effectiveness of gemfibrozil and bezafibrate in various types of hyperlipoproteinemia]U Julius, C Hora, P Gross, et al.
Acta Diabetologica|February 23, 2013
Effects of insulin glargine versus metformin on glycemic variability, microvascular and beta-cell function in early type 2 diabetesF Pistrosch, C Köhler, F Schaper, et al.
European Heart Journal|December 20, 2003
Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studiesM Hanefeld, M Cagatay, T Petrowitsch, et al.
Annals of Clinical Research|January 1, 1988
More exercise for the hyperlipidaemic patients?M Hanefeld, S Fischer, U Julius, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 25, 2005
A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trialB H Charbonnel, D R Matthews, G Schernthaner, et al.
Diabetes/Metabolism Research and Reviews|September 24, 2004
Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative studyD R Matthews, B H Charbonnel, M Hanefeld, et al.
European Journal of Internal Medicine|March 15, 2002
Insulin resistance and metabolic parameters in type 2 diabetic patientsW Metzler, S Fischer, C Köhler, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 16, 2010
Effect of targeting normal fasting glucose levels with basal insulin glargine on glycaemic variability and risk of hypoglycaemia: a randomized, controlled study in patients with early Type 2 diabetesM Hanefeld, C Koehler, C Hoffmann, et al.
Pageof 49